203 related articles for article (PubMed ID: 21738009)
1. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.
Bate C; Williams A
Prion; 2011; 5(2):65-8. PubMed ID: 21738009
[TBL] [Abstract][Full Text] [Related]
2. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
Bate C; Williams A
J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
[TBL] [Abstract][Full Text] [Related]
3. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
Bate C; Nolan W; Williams A
J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
[TBL] [Abstract][Full Text] [Related]
4. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
Bate C; Nolan W; Williams A
Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
[TBL] [Abstract][Full Text] [Related]
5. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.
Bate C; Tayebi M; Williams A
Biochem J; 2010 Apr; 428(1):95-101. PubMed ID: 20196773
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
[TBL] [Abstract][Full Text] [Related]
7. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
Bate C; Tayebi M; Williams A
J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
[TBL] [Abstract][Full Text] [Related]
8. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
Bate C; Tayebi M; Williams A
BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
[TBL] [Abstract][Full Text] [Related]
9. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
Bate C; Williams A
Prion; 2012; 6(4):350-3. PubMed ID: 22895089
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.
Taraboulos A; Scott M; Semenov A; Avrahami D; Laszlo L; Prusiner SB
J Cell Biol; 1995 Apr; 129(1):121-32. PubMed ID: 7698979
[TBL] [Abstract][Full Text] [Related]
11. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.
Puig B; Altmeppen HC; Linsenmeier L; Chakroun K; Wegwitz F; Piontek UK; Tatzelt J; Bate C; Magnus T; Glatzel M
PLoS Pathog; 2019 Jan; 15(1):e1007520. PubMed ID: 30608982
[TBL] [Abstract][Full Text] [Related]
12. Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.
West E; Osborne C; Nolan W; Bate C
Biology (Basel); 2015 Jun; 4(2):367-82. PubMed ID: 26043272
[TBL] [Abstract][Full Text] [Related]
13. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
14. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
15. The prion protein and lipid rafts.
Taylor DR; Hooper NM
Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
[TBL] [Abstract][Full Text] [Related]
16. The role of lipid rafts in prion protein biology.
Lewis V; Hooper NM
Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
[TBL] [Abstract][Full Text] [Related]
17. Role of lipid rafts and GM1 in the segregation and processing of prion protein.
Botto L; Cunati D; Coco S; Sesana S; Bulbarelli A; Biasini E; Colombo L; Negro A; Chiesa R; Masserini M; Palestini P
PLoS One; 2014; 9(5):e98344. PubMed ID: 24859148
[TBL] [Abstract][Full Text] [Related]
18. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.
Bate C; Tayebi M; Williams A
Neuropharmacology; 2010; 59(1-2):93-9. PubMed ID: 20398681
[TBL] [Abstract][Full Text] [Related]
19. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
Baron GS; Caughey B
J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
